Bearish flow noted in GSK (GSK) Pharma with 1,131 puts trading, or 2x expected. Most active are Mar-25 33 puts and Jan-26 35 puts, with total volume in those strikes near 730 contracts. The Put/Call Ratio is 3.58, while ATM IV is up nearly 15 points on the day. Earnings are expected on February 5th.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- GSK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- European Commission authorizes Vocabria + Rekambys for HIV treatment
- GSK Pharma put volume heavy and directionally bearish
- GSK announces EMA accepted for review the MAA for depemokimab
- GSK announces new drug applications accepted for review in China, Japan
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue